Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
33.33
-0.38 (-1.13%)
At close: Apr 28, 2026, 4:00 PM EDT
34.38
+1.05 (3.15%)
After-hours: Apr 28, 2026, 6:30 PM EDT
Stoke Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 184.42 | 36.56 | 8.78 | 12.41 | - | |
| Revenue Growth (YoY) | 404.50% | 316.34% | -29.22% | - | - | |
| Gross Profit | 184.42 | 36.56 | 8.78 | 12.41 | - | |
| Selling, General & Admin | 67.09 | 48.79 | 41.32 | 38.92 | 31.9 | |
| Research & Development | 137.92 | 89.13 | 82.23 | 77.84 | 54.17 | |
| Operating Expenses | 205.01 | 137.93 | 123.55 | 116.76 | 86.07 | |
| Operating Income | -20.59 | -101.37 | -114.77 | -104.36 | -86.07 | |
| Interest Expense | -0.01 | -0.03 | -0.05 | - | - | |
| Interest & Investment Income | 13.77 | 12.66 | 9.96 | 3.12 | 0.12 | |
| Other Non Operating Income (Expenses) | -0.05 | -0.25 | 0.17 | 0.17 | 0.14 | |
| Pretax Income | -6.89 | -88.98 | -104.7 | -101.07 | -85.81 | |
| Net Income | -6.89 | -88.98 | -104.7 | -101.07 | -85.81 | |
| Net Income to Common | -6.89 | -88.98 | -104.7 | -101.07 | -85.81 | |
| Shares Outstanding (Basic) | 59 | 54 | 44 | 39 | 37 | |
| Shares Outstanding (Diluted) | 59 | 54 | 44 | 39 | 37 | |
| Shares Change (YoY) | 9.65% | 22.76% | 13.11% | 5.87% | 9.71% | |
| EPS (Basic) | -0.12 | -1.65 | -2.38 | -2.60 | -2.34 | |
| EPS (Diluted) | -0.12 | -1.65 | -2.38 | -2.60 | -2.34 | |
| Free Cash Flow | 44.92 | -87.05 | -82.68 | -35.83 | -68.11 | |
| Free Cash Flow Per Share | 0.76 | -1.61 | -1.88 | -0.92 | -1.85 | |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | - | |
| Operating Margin | -11.16% | -277.31% | -1307.21% | -841.24% | - | |
| Profit Margin | -3.73% | -243.42% | -1192.47% | -814.73% | - | |
| Free Cash Flow Margin | 24.36% | -238.15% | -941.72% | -288.82% | - | |
| EBITDA | -18.82 | -99.2 | -112.3 | -102.81 | -85.09 | |
| EBITDA Margin | -10.21% | -271.36% | - | - | - | |
| D&A For EBITDA | 1.77 | 2.18 | 2.47 | 1.55 | 0.97 | |
| EBIT | -20.59 | -101.37 | -114.77 | -104.36 | -86.07 | |
| EBIT Margin | -11.16% | -277.31% | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.